Announced
Completed
Financials
Tags
Private
Single Bidder
Acquisition
Minority
Completed
Hong Kong
Pharmaceuticals
biopharmaceuticals
Private Equity
Domestic
Friendly
Synopsis
Baring Private Equity Asia, a private equity firm, completed a $100m investment in Hutchison China MediTech, a biopharmaceutical company. “With this strategic investment, BPEA is demonstrating our long-term commitment to HUTCHMED, an emerging biopharma leader in Asia. The healthcare sector in China is a core area of investment focus for BPEA. HUTCHMED is developing and delivering highly differentiated oncology therapies to patients around the world and we look forward to working with the CEO and management team to support the company’s innovation and global growth aspirations," Jean Eric Salata, BPEA CEO and Founding Partner.
© COPYRIGHT 2024 MERGERLINKS LIMITED.
ALL RIGHTS RESERVED.
15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.